USFDA Grants Approval To Strides Pharma For Generic GERD Treatment Formulation
Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs. - Newsx